Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Enzolytics Inc (ID) ENZC

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV... see more

Current News ()

Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator

ACCESS Newswire September 18, 2024

Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement

ACCESS Newswire September 9, 2024

Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells

ACCESS Newswire August 20, 2024

Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications

ACCESS Newswire July 31, 2024

Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.

ACCESS Newswire July 29, 2024

Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release

ACCESS Newswire July 26, 2024

SAGALIUM RESPONDS TO COMPETITOR'S FALSE AND MISLEADING PRESS RELEASE

GlobeNewswire July 25, 2024

Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment

ACCESS Newswire July 1, 2024

Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology

ACCESS Newswire June 3, 2024

Opinion & Analysis ()

No current opinion is available.

Bullboard Posts ()

Undervalued Biotech Stocks to Watch

Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:$ENZC) 300% Run: $RMED, $SPPI, $HALB, $VXRT https://www.marketwatch.com/press...
Williaminvestor - May 15, 2023

On track for product on shelves by march!!

https://www.digitaljournal.com/pr/enzolytics-ipf-immune-is-the-perfect-choice-for-people-with-weakened-immune-systems#ixzz7L5P5KBMX
Djritzz - February 17, 2022

$ELZC 5 Reasons Why Enzolytics is a Compelling Choice!

5 Reasons Why Enzolytics is a Compelling Choice!   5 Reasons Why Enzolytics is a Compelling Choice!
AviseAnalytics - June 11, 2021

Next ENZC minus the selloff

$apc.v Get long. You'll be happy you did.  Some biggggg $$$ circling it!!
Goldnboy1 - March 16, 2021

Seriously?

Nobody is posting on this?   Fascinating company with a promising HIV drug. 
Towser7 - February 5, 2021

ENZC and BSSP

$ENZC if you follow ENZC , You need to follow and look into $BSSP , these companies have the same board of directors , and bssp submitted...
Dayngerdabs - January 13, 2021